IP Library Granted Patent US 9,527,825
Granted Patent B2
US 9,527,825 · App. 15/053,793 · Granted Dec 27, 2016

Purification of taxanes

Inventors: Brian A. Bucher (Boston, MA); Edward M. Desimone, III (Indianapolis, IN); Roland R. Franke (Gloucester, MA); Rex T. Gallagher (Hampton, MA); Barry J. Hand (Acton, MA); Christopher D. Howe (Beverly, MA); James H. Johnson (Edenton, NC); John S. Juchum (Kingston, NH); Marc A. Plante (Middleton, MA); T. G. Sambandam (Uxbridge, MA); Dong S. Yang (Quincy, MA)
Assignee: Phyton Holdings, LLC
C07D305/14C07D407/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,527,825
App. No.
15/053,793
Granted
Dec 27, 2016
Kind
B2
Abstract

Disclosed is a method of crystallizing docetaxel comprising combining docetaxel and at least one solubilizing solvent to obtain a solution, wherein the solubilizing solvent is methylene chloride and adding an anti-solvent to the solution to obtain a crystalline docetaxel, wherein the anti-solvent is water.

Claims (17)

1. A method of crystallizing docetaxel comprising:

(a) combining docetaxel and at least one solubilizing solvent to obtain a solution, wherein the solubilizing solvent is methylene chloride; and

(b) adding an anti-solvent to the solution to obtain a crystalline docetaxel, wherein the anti-solvent is water.

2. The method of claim 1 , further comprising recrystallizing the crystalline docetaxel.

3. The method of claim 2 , wherein the recrystallization comprises:

(c) combining the crystalline docetaxel and a solubilizing solvent to obtain a second solution; and

(d) adding an anti-solvent to the second solution.

4. The method of claim 1 , wherein the docetaxel used in step (a) is isolated from a taxane material comprising docetaxel obtained from a semi-synthesis or total synthesis process, the isolation process comprising:

loading or injecting the material on a column comprising a polyethyleneimine-bonded silica (PBS resin;

(ii) eluting docetaxel from the PBS resin; and

(iii) recovering the eluted docetaxel.

5. The method of claim 4 , wherein molecules used as reactants in the semi-synthetic or total synthetic process are not derived solely from Taxus brevifolia.

6. The method of claim 4 , wherein the material loaded or injected on the column comprises less than about 8% by weight of C-2′ benzoyl primary taxanes.

7. The method of claim 4 , wherein the PBS resin is diethylaminomethyl (DEAM).

8. The method of claim 4 , wherein the PBS resin is polyethyleneimine (PEI).

9. The method of claim 8 , wherein the amino groups of the PEI are functionalized.

10. The method of claim 4 , wherein the PBS resin has an average pore size ranging from about 60 to about 800 Angstrom Units and an average particle size ranging from about 0.25 to about 500 microns.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2016
From: JOHNSON, JAMES H; HAND, BARRY J; FRANKE, ROLAND R; BUCHER, BRIAN A; JUCHUM, JOHN S; GALLAGHER, REX T; PLANTE, MARC A; DESIMONE, III, EDWARD M; YANG, DONG S
To: NATURAL PHARMACEUTICALS, INC.
Reel/Frame 038079/0392 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2016
From: NATURAL PHARMA CANADA, ULC; NATURAL PHARMACEUTICALS, INC.
To: PHYTON, INC.
Reel/Frame 038080/0033 →
EMPLOYEE PROPRIETARY INFORMATION AGREEMENT ATTACHED AS APPENDIX TO ASSIGNMENT Recorded Mar 23, 2016
From: SAMBANDAM, T.G.; HOWE, CHRISTOPHER D
To: NATURAL PHARMACEUTICALS, INC.
Reel/Frame 038229/0887 →
CHANGE OF NAME Recorded Mar 23, 2016
From: PHYTON, INC.
To: PHYTON HOLDINGS, LLC
Reel/Frame 038230/0028 →
Continuity (8)
Continuation 14188416 · Feb 24, 2014
Continuation 12705247 · Feb 12, 2010
Continuation 11764362 · Jun 18, 2007
Continuation 10549490
Continuation 10664539 · Sep 18, 2003
Provisional Application 60456478 · Mar 21, 2003
Provisional Application 60455377 · Mar 17, 2003
Related Publication 20160176837A1 · Jun 23, 2016